News
Advertisement Advertisement The new FDA leadership still recommends that groups ... since they would be conducted after the vaccine is released in what the agency calls post-marketing studies. The FDA ...
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
Here, we take a look at who’s in at the FDA, who’s out, and what could be next for the agency’s leadership ... navigating the future of the FDA’s vaccine division at a time when HHS ...
The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...
In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump ...
The Food and Drug Administration has named a vocal critic of the agency’s policies around administration of the COVID-19 vaccine to be the next head of the center responsible for regulating ...
53. WASHINGTON — Food and Drug Administration Commissioner Marty Makary said the agency is planning to unveil new guidance for vaccine makers, focused primarily on Covid-19 shots, in the coming ...
The Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results